Mandate

Vinge has advised Rottneros

September 06, 2017

Vinge has advised Rottneros AB (publ) (“Rottneros”) in connection with an issue of unsecured bonds up to a total amount of SEK 600 million.

The bonds have a term of five years and floating interest of STIBOR 3M + 4.15 per cent. Swedbank has acted as financial adviser and sole bookrunner in connection with the bond issue.

The proceeds from the initial bond issue will be used as part of completing the financing of the strategic plan Agenda 500 and for achieving long-term efficiency of the Group's capital structure. The bonds are, in accordance with their terms and conditions, intended to be admitted to trading on the corporate bond list of Nasdaq Stockholm.

Vinge’s team consisted of Louise Salomon together with André Isacson and Lionardo Ojeda.

Related

Vinge advises Aspo on its acquisition of Swed Handling

Vinge advises Aspo, listed on Nasdaq Helsinki, in the transaction whereby Aspo's subsidiary Telko expands its chemicals business in Sweden by acquiring Swed Handling, a leading Swedish chemical distributor, from TeRa Invest. As part of the transaction, Aspo’s subsidiary Leipurin expands its food industry business in Sweden, via the technical food ingredient distributor Kebelco, which is a subsidiary of Swed Handling. The closing of the transaction is subject to customary regulatory approvals.
April 30, 2024

Vinge advises on the sale of Vinnergi Holding AB

Vinge has advised Sobro and other shareholders in connection with the sale of Vinnergi Holding AB to Polaris, a Nordic investment firm. In connection with the transaction, the management and employees are reinvesting a significant portion to further develop the company. The Vinnergi Group conducts operations in technology consulting and software development in Sweden, with a particular focus on telecoms, energy and real estate.
April 30, 2024

Vinge has advised Pareto Securities in connection with a rights issue in Episurf Medical

Vinge has advised Pareto Securities in connection with a partially secured rights issue of units of up to approximately SEK 120 million in Episurf Medical.
April 24, 2024